查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714318

生物光子學市場－全球產業規模、佔有率、趨勢、機會與預測，按技術、應用、最終用戶、地區和競爭細分，2020-2030 年

Biophotonics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Technology, By Application, By End User, By Region, & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年生物光子學市場價值為 676.7 億美元，預計到 2030 年將達到 1,292.7 億美元，複合年成長率為 11.35%。這一成長是由光技術的重大進步和全球日益成長的醫療保健需求所推動的。生物光子學——利用光研究生物材料——在診斷、成像、治療和藥物開發中發揮關鍵作用。雖然醫療診斷仍然是主要的應用領域，但食品安全、環境監測和農業等非醫療產業正在迅速採用這些技術來完成污染檢測和作物健康評估等任務。隨著世界各地的醫療保健系統尋求更準確、早期和非侵入性的診斷解決方案，生物光子學正在成為一種變革工具。光學成像、光譜學、生物感測和人工智慧整合系統的持續創新有望進一步擴大其在醫療保健和科學領域的作用，使生物光子學成為未來生物醫學和環境解決方案的重要組成部分。

市場概覽
預測期 2026-2030
2024年市場規模 676.7億美元
2030年市場規模 1292.7億美元
2025-2030 年複合年成長率 11.35%
成長最快的領域 體外
最大的市場 北美洲

關鍵市場促進因素

慢性病盛行率不斷上升，人口老化加劇

主要市場挑戰

生物光子學設備和實施成本高昂

主要市場趨勢

人工智慧和機器學習與生物光子學的融合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：生物光子學市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依技術（體外、體內）
    • 依應用（透視成像、顯微鏡、內部成像、光譜分子、分析感測、光療、表面成像、生物感測器）
    • 按最終用戶（測試和組件、醫學治療、醫學診斷、非醫療應用）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美生物光子學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物光子學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太生物光子學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲生物光子學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲生物光子學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球生物光子學市場：SWOT 分析

第 14 章：競爭格局

  • Thermo Fisher Scientific Inc
  • Nu Skin Enterprises Inc
  • Becton Dickinson & Co
  • Glenbrook Technologies Inc
  • HAMAMATSU PHOTONICS KK
  • Olympus Corp
  • Carl Zeiss AG
  • Oxford Instruments PLC
  • ZENALUX BIOMEDICAL, INC.
  • PerkinElmer Health Sciences Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16105

The Biophotonics Market was valued at USD 67.67 billion in 2024 and is projected to reach USD 129.27 billion by 2030, growing at a CAGR of 11.35%. This growth is being driven by significant advancements in light-based technologies and increasing healthcare needs across the globe. Biophotonics-utilizing light to study biological materials-plays a critical role in diagnostics, imaging, therapy, and drug development. While medical diagnostics remains the primary application area, non-medical industries such as food safety, environmental monitoring, and agriculture are rapidly adopting these technologies for tasks like contamination detection and crop health evaluation. As healthcare systems worldwide seek more accurate, early-stage, and non-invasive diagnostic solutions, biophotonics is emerging as a transformative tool. Ongoing innovation in optical imaging, spectroscopy, biosensing, and AI-integrated systems is expected to further expand its role across healthcare and scientific domains, making biophotonics an essential part of future biomedical and environmental solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 67.67 Billion
Market Size 2030USD 129.27 Billion
CAGR 2025-203011.35%
Fastest Growing SegmentIn-vitro
Largest MarketNorth America

Key Market Drivers

Growing Prevalence of Chronic Diseases and Aging Population

The increasing burden of chronic diseases and a rapidly aging global population are major drivers of the biophotonics market. Chronic conditions such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders are becoming more prevalent due to aging demographics, urbanization, and lifestyle factors. In 2021, non-communicable diseases (NCDs) were responsible for about 43 million deaths-75% of non-pandemic-related mortality-with 18 million premature deaths occurring before the age of 70, primarily in low- and middle-income countries. This rising health burden demands precise, non-invasive, and cost-effective diagnostic technologies. Biophotonics offers advanced tools such as optical coherence tomography (OCT), fluorescence imaging, Raman spectroscopy, and biosensors that enable early detection and continuous monitoring of chronic diseases. These technologies enhance clinical decision-making, reduce healthcare costs, and support better long-term patient outcomes, making them highly valuable in addressing global healthcare challenges.

Key Market Challenges

High Cost of Biophotonics Equipment and Implementation

A significant challenge in the biophotonics market is the high cost associated with advanced equipment and implementation. Devices like Raman spectrometers, OCT systems, and fluorescence microscopes require substantial capital investment, often making them inaccessible to smaller hospitals, research institutions, and facilities in emerging economies. Beyond hardware, the total cost includes expenses related to integration with existing systems, skilled personnel for operation, ongoing maintenance, and training, all of which further increase the financial burden. These high costs restrict the widespread adoption of biophotonics technologies, especially in cost-sensitive regions, ultimately limiting the market's growth potential. For broader uptake, especially in underserved areas, manufacturers must work toward developing cost-effective solutions and improving accessibility without compromising on performance.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning with Biophotonics

A pivotal trend transforming the biophotonics landscape is the integration of Artificial Intelligence (AI) and Machine Learning (ML) with photonic technologies. AI-driven algorithms are increasingly used to analyze complex data from imaging and spectroscopy tools, enhancing the speed, precision, and accuracy of disease diagnosis. In applications like cancer detection and neurological assessment, AI models help recognize patterns, improve image resolution, and provide real-time feedback, thus enabling earlier and more accurate interventions. The combination of AI with biophotonics is particularly impactful in optical imaging systems, where it improves sensitivity and specificity. Additionally, AI enhances the personalization of diagnostics and treatment plans, optimizing healthcare delivery. As data-driven medicine continues to evolve, the fusion of AI and biophotonics is expected to reduce diagnostic errors, streamline workflows, and elevate the overall efficiency of healthcare systems globally.

Key Market Players

  • Thermo Fisher Scientific Inc
  • Nu Skin Enterprises Inc
  • Becton Dickinson & Co
  • Glenbrook Technologies Inc
  • HAMAMATSU PHOTONICS K.K.
  • Olympus Corp
  • Carl Zeiss AG
  • Oxford Instruments PLC
  • ZENALUX BIOMEDICAL, INC.
  • PerkinElmer Health Sciences Inc

Report Scope:

In this report, the Global Biophotonics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biophotonics Market, By Technology:

  • In-Vitro
  • In-Vivo

Biophotonics Market, By Application:

  • See-Through Imaging
  • Microscopy
  • Inside Imaging
  • Spectro Molecular
  • Analytics Sensing
  • Light Therapy
  • Surface Imaging
  • Biosensors

Biophotonics Market, By End User:

  • Tests and Components
  • Medical Therapeutics
  • Medical Diagnostics
  • Non-medical Application

Biophotonics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biophotonics Market.

Available Customizations:

Global Biophotonics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Biophotonics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (In-Vitro, In-Vivo)
    • 5.2.2. By Application (See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, Biosensors)
    • 5.2.3. By End User (Tests and Components, Medical Therapeutics, Medical Diagnostics, Non-medical Application)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Biophotonics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biophotonics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Biophotonics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Biophotonics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Biophotonics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biophotonics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Biophotonics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Biophotonics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Biophotonics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Biophotonics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Biophotonics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biophotonics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Biophotonics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Biophotonics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Biophotonics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Biophotonics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Biophotonics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biophotonics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Biophotonics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Biophotonics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Biophotonics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biophotonics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Biophotonics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Biophotonics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Biophotonics Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Nu Skin Enterprises Inc
  • 14.3. Becton Dickinson & Co
  • 14.4. Glenbrook Technologies Inc
  • 14.5. HAMAMATSU PHOTONICS K.K.
  • 14.6. Olympus Corp
  • 14.7. Carl Zeiss AG
  • 14.8. Oxford Instruments PLC
  • 14.9. ZENALUX BIOMEDICAL, INC.
  • 14.10.PerkinElmer Health Sciences Inc.

15. Strategic Recommendations

16. About Us & Disclaimer